The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors

Valerie Rusch, John Mendelsohn, Ethan Dmitrovsky

Research output: Contribution to journalShort surveypeer-review

99 Scopus citations

Abstract

The epidermal growth factor receptor (EGFR) is detected on many non- haematopoietic tissues and is frequently overexpressed in human tumors. With its ligand, TGF-α, it forms a well-defined autocrine growth loop. Several clinical approaches, using EGFR as a therapeutic target, are being investigated, particularly monoclonal antibodies combined with chemotherapy, and pharmacological inhibition of downstream components of the EGFR signaling pathway.

Original languageEnglish (US)
Pages (from-to)133-141
Number of pages9
JournalCytokine and Growth Factor Reviews
Volume7
Issue number2
DOIs
StatePublished - Aug 1996

Keywords

  • EGFR
  • Human tumors
  • Ligands
  • Therapeutic targets

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Immunology
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors'. Together they form a unique fingerprint.

Cite this